A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD ; volume:21 ; number:1 ; day:10 ; month:2 ; year:2020 ; pages:1-11 ; date:12.2020
Respiratory research ; 21, Heft 1 (10.2.2020), 1-11, 12.2020
- Creator
-
Singh, Dave
Martinez, Fernando J.
Watz, Henrik
Bengtsson, Thomas
Maurer, Brian T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-020-1307-4
- URN
-
urn:nbn:de:101:1-2020051018254166723139
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Singh, Dave
- Martinez, Fernando J.
- Watz, Henrik
- Bengtsson, Thomas
- Maurer, Brian T.
- SpringerLink (Online service)
Other Objects (12)
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study
Dispersive Fourier transform based dual-comb ranging
Der Phosphodiesterase-4-Hemmer-Roflumilast : Fortschritt bei der Therapie der COPD
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach
Dual chirped microcomb based parallel ranging at megapixel-line rates
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study
Dispersive Fourier transform based dual-comb ranging
Der Phosphodiesterase-4-Hemmer-Roflumilast : Fortschritt bei der Therapie der COPD
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach
Dual chirped microcomb based parallel ranging at megapixel-line rates
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study
Dispersive Fourier transform based dual-comb ranging
Der Phosphodiesterase-4-Hemmer-Roflumilast : Fortschritt bei der Therapie der COPD
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach
Dual chirped microcomb based parallel ranging at megapixel-line rates